Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)
Clinical trial NCT02964013 · COMPLETED
Trial details
- NCT number
- NCT02964013
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2024-07-24
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.